ArticleJACC. Case reports2026
RYR1 Pathogenic Variant in a Patient With Overlapping Features of Brugada Syndrome and Arrhythmogenic Cardiomyopathy.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBrugada syndrome (BrS) and arrhythmogenic cardiomyopathy (ACM) may overlap clinically, but shared mechanisms remain unclear. RYR1 mutations have not been previously linked to these arrhythmia syndromes. CASE SUMMARY: A 32-year-old man with a family history of BrS presented with palpitations and positional ventricular tachycardia. Ajmaline testing unmasked a diagnostic type 1 BrS electrocardiographic pattern. Cardiac magnetic resonance showed subtle right ventricular dyskinesia and focal left ventricular fibrosis, meeting borderline ACM criteria. Electrophysiological study showed noninducible ventricular arrhythmias, but premature ventricular contractions were reproducibly provoked in the left-lateral position. After shared decision-making, an implantable cardioverter-defibrillator was implanted for primary prevention. Genetic testing revealed a pathogenic truncating RYR1 variant (p.Arg2920∗). DISCUSSION: This case illustrates a novel association of RYR1 mutation with overlapping BrS-ACM features. Shared connexome and calcium-handling abnormalities may underlie this phenotype. TAKE-HOME MESSAGES: RYR1 mutations may contribute to overlapping BrS-ACM phenotypes. Careful imaging, provocative testing, and genetic assessment can guide management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.